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Abstract 
Background: Red blood cell (RBC) transfusion has been associated with nosocomial infection in the critically ill 
patients. However, this association may be confounded by length of stay, as prolonged intensive care unit (ICU stay) 
increases both risk of infection and risk of transfusion. Also, it is not known whether specific blood products have dif-
ferential risks.
Methods: In this prospective multicentre cohort study, the risk of bacterial infections associated with transfusion 
products in critically ill (ICU) patients was determined in an integrated statistical model, using Cox proportional hazard 
analysis to account for attrition bias. In all acutely admitted patients with a length of stay of >48 h between 1 January 
2011 and 31 December 2012, the occurrence of nosocomial infections in the ICU was prospectively monitored using 
CDC criteria.
Results: Of 3502 screened patients, 476 (13.6 %) developed a nosocomial infection. These patients had higher 
APACHE IV scores, had longer ICU length of stay and were more frequently transfused compared to patients without 
an infection. Logistic regression showed that RBC transfusion was a risk factor for infection [odds ratio (OR) 1.98, 95 % 
confidence interval (CI) 1.54–2.55, p < 0.001], as well the number of RBC units transfused (OR 1.04, 95 % CI 1.03–1.06, 
p < 0.001). However, these associations disappeared in the Cox proportional hazard analysis. In contrast, we found 
an association between plasma transfusion and infection [hazard ratio (HR) 1.36, 95 % CI 1.10–1.69, p = 0.004] and 
between platelet transfusion and infection (HR 1.46, 95 % CI 1.18–1.81, p < 0.001). However, only platelet transfusion 
was associated with infection independently from other transfusion products (HR 1.40, 95 % CI 1.03–1.90, p = 0.03).
Conclusions: In critically ill patients, transfusion of platelets, but not of RBCs and plasma, is an independent risk fac-
tor for acquiring a nosocomial infection.
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Background
In medical and surgical critically ill patient populations, 
an increased risk of nosocomial infections following red 
blood cell (RBC) transfusion has repeatedly been dem-
onstrated in observational studies [1–11]. The risk of 
infection following RBC transfusion has been related to 
the amount of transfused blood [1, 2, 7] as well as to RBC 
storage lesion, although studies show conflicting results 
on the association between storage duration and infec-
tion [2, 4–6, 8, 11]. Given that the chance of receiving 
stored blood increases when the amount of transfusion 
is higher, it is a challenge to determine whether increased 
risk of infection following transfusion is due to storage 
or due to the number of transfused units. Regardless of 
the mechanism, the association between transfusion 
and infection can be confounded by length of stay in 
the intensive care unit (ICU), because both the risk of 
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receiving a (stored) blood transfusion and the risk of 
developing an infection increase during prolonged ICU 
stay. This is called attrition bias. Previous studies have 
not always accounted for this type of bias.
As RBCs are often administered together with plasma 
and platelets, another challenge may be to dissect 
whether these other blood products influence the risk 
of infection. This is relevant, as also platelet transfusions 
have been associated with post-operative infection in 
cardiac surgery patients [12] and in critically ill patients 
recovering from sepsis [13]. These immunosuppres-
sive effects of transfused platelets have been related to 
alterations in their expression of MHC class I molecules 
[14]. Also, plasma has been related to infectious com-
plications. An observational study found that plasma 
increased the risk of infection in critically ill surgical 
patients, which was not due to concomitant RBC trans-
fusion [15]. Also in cardiac surgery, FFP was associated 
with nosocomial infection [16].
The purpose of this prospective cohort study was to 
investigate the risk of nosocomial infections following 
transfusion in critically ill patients. We hypothesized that 
the number of blood products was independently associ-
ated with an increased risk of nosocomial infection. Cox 
regression was used to adjust for the effect of attrition 
bias. An integrated model was used to study the inde-
pendent effect of the different blood products.
Methods
Design and subjects
This study was performed within the framework of the 
Molecular Diagnosis and Risk stratification of Sepsis 
(MARS) project [17]; a prospective observational cohort 
study was performed in the mixed surgical–medical ICU 
of two university hospitals in the Netherlands, in which 
all admissions between the period of 1 January 2011 and 
31 December 2012 were included, with the exception of 
cardiac surgery patients. The presence of bacterial noso-
comial infection was the primary outcome of this study. 
The medical ethics committees of the participating study 
centres gave approval for an opt-out consent method 
(IRB number 10-056C). Patients with an ICU stay of less 
than 48 h were excluded.
Outcomes
All data were gathered prospectively by a team of trained 
research fellows, using an electronic format. Scoring of 
nosocomial infection was performed daily based on cri-
teria adapted from the Centre of Disease Control that 
were published previously [17]. These criteria included 
the source of infection, the causative pathogen and the 
plausibility of infection (none, possible, probable and def-
inite). Infections are both post-surgical and non-surgical. 
Only the first infection episode was included in this study. 
Detailed definitions of infection are given in Additional 
file  1. In this study, patients with a possible, probable 
or definite bacterial infection were included. The over-
all inter-observer variability for all sites of infection was 
89  %, as previously reported [17]. A cleaning algorithm 
was used, which alarmed the researchers of inconsistency 
of data, after which a hand check of the data was done. 
Use of this algorithm resulted in an increase in inter-
observer agreement to 85  % for ventilator-associated 
pneumonia (VAP) [15], which accounted for 26 % of the 
nosocomial infections in this study.
Risk factors for infection
Potential confounders were selected based on previous 
data [13, 18] and included mechanical ventilation, sepsis 
at ICU admission, Acute Physiology and Chronic Health 
Evaluation (APACHE) predicted length of stay, admission 
type, cancer, immunosuppressive medication, immuno-
suppressive condition and trauma.
 As part of standard care, patients with an anticipated 
ICU stay of more than 2  days received either selective 
digestive tract decontamination (SDD, consisting of a 
non-absorbable solution of tobramycin, colistin and 
amphotericin B administered in the buccal cavity and 
as a suspension through the nasogastric tube, given for 
the length of ICU stay, combined with cefotaxime given 
for 4  days), or selective oropharyngeal decontamina-
tion (SOD, consisting only of administration of the non-
absorbable solution in the oropharynx). Transfusion data 
(date of infusion, type and amount of blood product) of 
all blood transfusions which were given during ICU stay 
and 1  week prior to ICU admission were prospectively 
registered in a patient digital monitoring system. The 
storage time of blood products was obtained from the 
hospital blood transfusion service. In patients who devel-
oped a nosocomial infection, only transfusions given 
before the onset of infection were evaluated. Per blood 
product, a qualitative variable (transfusion yes or no) and 
a quantitative variable (amount of product in units) were 
generated. Stratification for RBC storage time was done 
dichotomous (>14  days). RBCs were stored in SAGM. 
Platelet products were pooled from 5 donors and stored 
in plasma. All blood products were prestorage leuko-
reduced. Fresh-frozen plasma (FFP) was prepared from 
male donors only.
Transfusion protocols were similar in both institu-
tions, holding that one RBC unit is transfused to correct 
for anaemia at a general haemoglobin trigger of 7 g/dL. 
A unit of pooled platelets from 5 donors is transfused 
prophylactically at a platelet count of 10  ×  109/L or of 
50 × 109/L in case of use of antiplatelet medication. FFPs, 
RBCs and platelets are liberally transfused at a 1:1:1 ratio 
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(i.e. five units erythrocytes/five units FFP/one 5-donor 
unit platelets) during haemorrhage.
Statistical analysis
We analysed the association between nosocomial infec-
tion and RBCs, FFPs or platelets separately. We corrected 
for potential confounders, the risk of receiving a trans-
fusion (using propensity scores) and attrition bias (ICU 
observation period) using a five-step approach described 
below and visualized in Additional file 2: Figure S1. First, 
we evaluated which features of the blood transfusions 
(qualitative; transfusion yes/no; quantitative; total num-
ber; and/or the age of blood products) were associated 
with infection (details in Additional file 2: Figure S1). A 
logistic regression model with nosocomial infection as 
the dependent variable was used, and non-informative 
variables were removed using backward selection by 
Akaike information criterion (AIC). Second, the effect 
of transfusion was corrected for confounding effects 
(see Additional file 2). As in step one, we used backward 
selection to identify confounders from a group of pre-
defined variables (see risk factors for infection). Third, 
propensity scores (for explanation, see Additional file 2) 
were calculated to estimate the influence of the a priori 
likelihood of receiving a blood transfusion on the devel-
opment of a nosocomial infection using a logistic regres-
sion model with transfusion as dependent variable. The 
propensity score was added as a co-variate in the logistic 
regression model with nosocomial infection as depend-
ent variable. Fourth, we adjusted for the effect of attrition 
bias (ICU observation period) by means of Cox regres-
sion. Cox regression was performed with the same inde-
pendent variables (transfusion features, confounders and 
propensity score) as in step 3. A Kaplan–Meier curve 
was used to visualize the hazard of nosocomial infec-
tion per transfusion product. A sensitivity analysis with 
a mixed-effect Cox proportional hazards model was per-
formed to evaluate the differences in effect size between 
the two hospitals. The impact of missing data was stud-
ied by repeating the previous analyses after multivariate 
imputation by chained equations and comparing the pro-
portional hazard between the model with and without 
missing data. Finally, we studied the independent associ-
ation of the three transfusion products with nosocomial 
infection by inclusion of all variables that were selected 
in the three previous models into one Cox proportional 
hazard model. Only features of transfusion that remained 
significantly associated with infection in this step were 
considered to be independently associated with nosoco-
mial infection.
Differences between the groups were compared using 
the Student’s T test (normally distributed variables) or 
Mann–Whitney test (non-normally distributed variables) 
for continuous variables. The Chi-square test was used 
for categorical variables. Data were summarized using 
the mean and standard deviation (SD) for normally dis-
tributed variables and the median and inter-quartile 
range (IQR) for non-normally distributed variables. 
Categorical variables were expressed in absolute num-
bers and percentages. All analyses were performed in R 
statistics using the RStudio interface (www.rstudio.com, 
version 0.98.501). p values below 0.05 were considered 
significant.
Results
Of 3502 ICU patients, 37  % were transfused with any 
blood product. Patients were most frequently transfused 
on the first day of ICU admission. With regard to the total 
cohort, 476 patients (13.6  %) developed a nosocomial 
bacterial infection during their ICU stay. The median 
time to infection was 6  days (IQR 3–10). Of all infec-
tions, 56 % occurred early (0–6 days) and 44 % occurred 
late (>6 days). With regard to the probability of infection, 
28 % of infected patients were scored as having a definite 
infection, 17 % had a probable infection and 55 % had a 
possible infection (for definitions, see Additional file 2). 
Characteristics summarized for the patients with infec-
tion and without an infection are listed in Table  1. The 
median ICU stay of patients who developed a nosocomial 
infection was longer compared to patients who did not 
develop an infection [14 (IQR 8–26) vs. 4 (IQR 2–7) days, 
respectively]. Furthermore, patients with an infection 
had a significant higher APACHE IV score compared to 
patients without an infection. The most frequent site of 
infection was the respiratory tract (51 %). Gram-positive 
pathogens were the most frequent organisms found in 
nosocomial infections (Table 2). 
Overall, RBCs were given in 35 % of admitted patients, 
FFP in 17  % and platelets in 18  % of patients. Most 
patients (46 %) were transfused on the day of ICU admis-
sion. Transfusion characteristics are listed in Table 3 and 
Additional file 2: Table S1. Patients receiving transfusion 
had a higher APACHE IV score than non-transfused 
patients. There were no apparent differences between 
patients receiving RBCs and those receiving other blood 
products. The patients with infection more often received 
transfusion compared to the patients without infection, 
including more units stored for prolonged time.
Red blood cells The median storage time of RBC units 
in this study was 20 days (IQR 16–23). Forty-seven per-
centage of the patients with infection received at least 
one RBC unit older than 14  days and 34  % received at 
least one RBC unit older than 21 days. The patients with 
infection received a larger amount of RBC units and a 
larger amount of older RBC units compared to patients 
without infection (Table 3).
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Logistic regression identified both transfusion of RBC 
as a qualitative, dichotomous variable (yes or no) and 
amount of transfusion as independent predictors for 
nosocomial infection. This association remained sig-
nificant after adjustment for potential confounders and 
exposure bias to transfusion (the risk of receiving a trans-
fusion). However, the proportional hazard model showed 
no significant association between nosocomial infection 
and both RBC transfusion and amount of transfusion 
(Table  4). We did not observe an independent associa-
tion between the storage time (RBC units >14 and RBC 
units >21 days) of RBCs and onset of nosocomial infec-
tion (Additional file 2: Table S2).
FFP The logistic regression model identified FFP trans-
fusion as a risk factor for nosocomial infection. This 
association persisted in the proportional hazard model 
(Table 4). We found no association between the amount 
of FFP transfusion and nosocomial infection.
Platelets In the sub-analysis with platelets, both logistic 
regression model and Cox regression showed that trans-
fusion of platelets was an independent risk factor for the 
onset of nosocomial infection. A hazard of 1.40 means 
that a subject’s hazard at any given time is increased rela-
tive to the baseline hazard with 40 %, while the baseline 
hazard may vary.
Combined analysis In the combined analyses for the 
three different types of blood transfusions, only platelet 
transfusion remained as an independent risk factor for 
the development of nosocomial infection, i.e. independ-
ent from the effect of RBCs and plasma (Table 5).
Sensitivity analysis To evaluate the differences in effect 
size between the two hospitals, mixed-effect Cox regres-
sions were done, which showed similar effect sizes, sug-
gesting stable models. The Cox models with imputed 
missing data showed a significant effect for FFP trans-
fusion and platelets transfusion, suggesting that missing 
data did not influence results. The influence of pre-ICU 
transfusions was also investigated, as these may influence 
risk of infection while on ICU. Additional file 2: Tables S5 
and S6 show that the different outcomes were not sen-
sitive to exclusion of the pre-ICU transfusion period. To 
correct for disease severity occurring later during ICU 
admission, the model was re-run with SOFA score on 
day 3. The HR of infection following platelet transfusion 
remained significant in this model.
Discussion
This study did not demonstrate an association between 
RBC transfusion and nosocomial infection in ICU 
patients after adjusting for ICU length of stay. However, 
we found that transfusion of platelets was independently 
associated with nosocomial infection.
Differences between our results and previous studies 
[1, 2, 7, 19], which demonstrated an association between 
RBC transfusion and infection, may be explained by the 
use of different statistical analysis methods. Our results 
are based on both multivariate logistic regression and 
Cox regression, whereas in previous studies, Cox regres-
sion is often not used, thereby not accounting for expo-
sure time. Correcting for exposure time in this study may 
Table 1 Baseline characteristics
APACHE Acute Physiology and Chronic Health Evaluation, HIV human immunodeficiency virus, IQR inter-quartile range, SD standard deviation
Overall (N = 3502) Infected (N = 476) Non-infected (N = 3026) p value
Mean age (years ± SD) 59.1 ± 16.2 59.6 ± 15.9 59.0 ± 16.3 <0.001
Gender, male [n (%)] 2129 (61) 310 (65) 1819 (60) 0.04
APACHE IV score, median (IQR) 72 (54–92) 79 (63–100) 71 (53–91) <0.001
Readmission [n (%)] 552 (16) 83 (17) 469 (15) 0.28
Admission type 0.01
 Medical [n (%)] 2040 (58) 252 (53) 1788 (59)
 Surgical elective [n (%)] 665 (19) 91 (19) 574 (19)
 Surgical emergency [n (%)] 795 (23) 133 (28) 662 (22)
Any transfusion [n (%)] 1304 (37) 288 (61) 1016 (34) <0.001
Solid malignancy [n (%)] 454 (13) 54 (11) 400 (13) 0.26
Haematologic malignancy [n (%)] 137 (4) 20 (4) 117 (4) 0.73
Immunosuppressive condition (n) 392 (11) 56 (12) 336 (11) 0.67
 HIV infection [n (%)] 41 (1) 6 (1) 35 (1) 0.84
 Immunosuppressive medication [n (%)] 367 (10) 54 (11) 313 (10) 0.51
Trauma [n (%)] 280 (8) 51 (11) 229 (8) 0.02
Mechanical ventilation [n (%)] 3127 (89) 455 (96) 2672 (88) <0.001
Sepsis [n (%)] 1544 (44) 189 (40) 1355 (45) 0.04
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have negated the finding of an association of RBC and 
infection, suggesting that both transfusion and infection 
are conditions that occur as a result of ICU stay but are 
not causally related. Alternatively, differences may be 
explained by using different models. Of note, plasma or 
platelets are mostly transfused concomitantly with RBCs. 
In this study, risks of blood products were analysed in one 
model instead of analysing effects of products separately, 
which is more comparable to real life. Explanations other 
than different statistical methods include differences in 
preparation methods and use of storage solutions. Also, 
differences in case mix may explain different findings, as 
most studies on transfusion and infection were done in 
trauma patients.
We did not find an association between RBC stor-
age time and nosocomial infection. This is in contrast to 
other studies [3, 6], but in line with recent large trials in 
which ICU patients or cardiac surgery patients were ran-
domized to fresh or stored blood [4, 20].
We found that the hazard ratio of infection was higher 
in patients receiving platelets, an effect that was inde-
pendent of the other transfusion products. Besides their 
haemostatic potential, platelets are recognized to play a 
role in innate immunity, including activation and hom-
ing of leucocytes and production of pro-inflammatory 
cytokines [21]. In line with this, transfusion of platelets 
can induce transfusion-associated immunomodulation 
in a mouse model, associated with the expression of 
platelets MHC class I antigens [14]. Clinical studies also 
underline an association between platelet transfusion and 
infection [12, 13, 16], although not all studies are con-
sistent [22]. Given that RBCs were not associated with 
occurrence of infection in the large group of patients that 
received only RBCs in this study, it is unlikely that RBCs 
contributed to the risk of infections when administered 
together with platelets. Alternatively, one may argue 
that patients receiving platelets are mostly haematologic 
patients who are at risk of nosocomial infections. How-
ever, patient characteristics did not differ between those 
receiving platelets and those receiving other blood prod-
ucts. Thereby, this study suggests that platelet transfu-
sions are the most important blood products associated 
with increased risk of infection in the critically ill. The 
mechanism by which platelets may reduce host response 
to infection remains to be determined.
Does this finding have clinical relevance? Arguably, if 
indicated, platelet transfusions cannot be omitted. How-
ever, clear indications for platelet transfusion in ICU 
patients are lacking. Prophylactic platelet transfusion 
prevents bleeding in haematology patients [23], but it 
is not known at which count platelets should be trans-
fused in ICU patients to prevent bleeding. Protocols at 
both centres pragmatically suggest a count of 10,000 as 
a trigger for transfusion in ICU patients and a trigger of 
50,000 when the patient needs treatment with antico-
agulant medication. These suggestions are, however, not 
substantiated with data. The lack of data on clear indica-
tions, together with the suggestion of possible harm in 
this study, calls for studies on the risk–benefit of platelet 
transfusion in the critically ill.
This study has some important limitations. Causal-
ity between platelet transfusion and infection cannot be 
established in this study. Even after adjustment for ill-
ness severity, platelet transfusion may still be a surrogate 
marker for sicker patients. Causality can only be deter-
mined in an RCT. Also, half of the patients complied 
to the definition of possible infection, which may have 
induced misclassification, including those with a post-
transfusion reaction. Statistical modelling using only 
patients with definite infection was not possible in this 
study due to a lack of power, even in this relatively large 
cohort. However, even if this analysis was possible, the 
Table 2 Site of  infection and  causative organisms 
in infected patients
HAP hospital-acquired pneumonia, VAP ventilator-acquired pneumonia, IAI intra-




 Respiratory tract (HAP, VAP, empyema) 242 (42.0)
 Intra-abdominal (peritonitis, biliary tract infection, abscess) 42 (8.8)
 Cardiovascular (BSI, endocarditis, mediastinitis) 88 (18.5)
 Soft tissue (erysipelas, phlebitis, abscess, decubitus  
infection)
12 (2.5)
 Post-operative wound (superficial, deep) 11 (2.3)
 Renal/urinary tract (urosepsis, upper urinary tract infection) 9 (1.9)
 Central nervous system (brain abscess, meningitis) 44 (9.2)
 Others (bones/joints, reproductive system, oral infections) 14 (2.9)
 Unknown 10 (2.1)
Microorganisms
 Gram-positive 148 (31.0)
  Staphylococcus aureus 38 (8.0)
  Staphylococcus epidermis 26 (5.5)
  Streptococcus species 10 (2.1)
  Enterococcus species 65 (13.7)
  Other 9 (1.9)
 Gram-negative 139 (28.6)
  Enterobacteriaceae species 68 (14.3)
  Haemophilus influenza 18 (3.8)
  Pseudomonas species 40 (8.4)
  Other 13 (2.7)
 Other 10 (2.1)
  Anaerobes 6 (1.3)
  Unknown 173 (36.3)
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use of a very strict definition (e.g. culture positive sep-
sis) may lead to selection bias, as the amount of culture 
negative patients is known to be more than one-third of 
all sepsis patients [24]. Also, the use of clear definitions 
in this study limited subjectivity of classification, as sug-
gested by a low inter-observer variation in this study. 
Still, the diagnosis of infection remains an uncertainty in 
this observational study, requiring follow-up studies to 
affirm our findings.
Other limitations of this study include preparation 
method. Our results may not be translated to other 
settings where these methods differ. Furthermore, among 
ICU centres there is variability in ICU-specific factors, 
which can lead to heterogeneity in nosocomial infec-
tion hazard rates. Of these, the use of SDD may be the 
most important. Whether the results in this paper can be 
extrapolated to centres that do not use SDD remains to be 
determined. Lastly, although we accounted for exposure 
bias that is a well-known confounder in studies investi-
gating risk factors for nosocomial infection, standard 
Cox regression analysis is limited in correcting for time-
dependent bias and competing risks. However, this study 
Table 3 Transfusion characteristics
RBC red blood cells, FFP fresh-frozen plasma, IQR inter-quartile range
Patients Overall (n = 3502) Infected (N = 476) Non-infected (N = 3026) p value
RBC [n (%)] 1235 (35) 272 (57) 963 (32) <0.001
RBC > 14 days [n (%)] 1053 (30) 224 (47) 829 (27) <0.001
FFP [n (%)] 602 (17) 159 (33) 443 (15) <0.001
Platelets [n (%)] 621 (18) 157 (33) 464 (15) <0.001
Time between (first) transfusion and infection (days)
 RBC [median (IQR)] 6 (3–10)
 FFP [median (IQR)] 6.5 (4–10)
 Platelets [median (IQR)] 7 (4–10)
Blood products in transfused patients Overall (n = 1304) Infected (n = 288) Non-infected (N = 1016) p value
RBC
 No. of units [median (IQR)] 4 (2–8) 5 (2–11) 4 (2–7) <0.001
 No. of units >14 days [median (IQR)] 3 (1–6) 4 (1–8) 2 (1–6) <0.001
FFP
 No. of units [median (IQR)] 0 (0–0) 0 (0–3) 0 (0–0) <0.001
 Platelets
 No. of units [median (IQR)] 0 (0–0) 0 (0–2) 0 (0–0) <0.001
Table 4 Analysis of association between transfusion products and nosocomial infection in separate models
FFP fresh-frozen plasma, RBC red blood cells
a Corrected for exposure bias (for RBC transfusion) summarized in propensity score including trauma, malignancy, admission type, APACHE IV score and sepsis. Also 
corrected for confounders including APACHE predicted length of stay and mechanical ventilation
b Corrected for exposure bias (for FFP transfusion) summarized in propensity score including admission type, APACHE IV score and sepsis. Also corrected for 
confounders including APACHE predicted length of stay and mechanical ventilation
c Corrected for exposure bias (for platelet transfusion) summarized in propensity score including admission type, malignancy, APACHE IV score and sepsis. Also 
corrected for confounders including APACHE predicted length of stay and mechanical ventilation
Blood product Logistic regression Cox regression
Odds ratio 95 % CI p value Hazard 95 % CI p value
Red blood cells
 RBC transfusiona 1.977 1.535–2.547 <0.001 1.143 0.906–1.442 0.259
 RBC unitsa 1.044 1.026–1.063 <0.001 1.014 1.000–1.028 0.053
Fresh-frozen plasma
 FFP transfusionb 2.510 1.978–3.186 <0.001 1.362 1.101–1.685 0.004
Platelets
 Platelet transfusionc 2.530 1.998–3.205 <0.001 1.463 1.184–1.806 <0.001
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also has strong aspects. We investigated the association 
between transfusion products and nosocomial infection 
with a prospective study design, using a structured evalu-
ation of all infectious events, to minimize the potential 
sources of bias and confounding. In addition, our study 
is characterized by a large sample size. Furthermore, the 
independent effect on nosocomial infections was studied 
for each type of transfusion product separately.
In conclusion, we investigated the association between 
different transfusion products and the onset of nosoco-
mial infection in the critically ill patients. We suggest that 
transfusion of platelets, but not of RBCs, is associated 
with infection. Further studies on the mechanisms of 
this association and on possible interventions which may 
modulate this risk are warranted.
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